Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Clinical Research
  • Published:

Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer?

Prostate Cancer and Prostatic Diseases volume 24, pages 507–513 (2021)Cite this article

Subjects

Abstract

Background

To assess whether prior interventional treatment for benign prostatic hyperplasia (BPH) influences oncologic or functional outcomes following primary whole-gland prostate cryoablation.

Methods

Among 3831 men with prostate cancer who underwent primary whole-gland prostate cryoablation, we identified 160 with a history of prior BPH interventional therapy including transurethral needle ablation (n = 6), transurethral microwave thermotherapy (n = 9), or transurethral resection of the prostate (n = 145). Patients with a history of medically treated or unspecified BPH therapy were excluded from the study. Oncological and functional outcomes were compared between men with and without prior BPH interventional therapy.

Results

In unadjusted analyses, prior interventional BPH therapy was associated with higher risks of postoperative urinary retention (17.5% vs. 9.6%, p = 0.001) and new-onset urinary incontinence (39.9% vs. 19.4%, p > 0.001) compared with no prior therapy. Interventional BPH therapy was not correlated with the risk of developing a rectourethral fistula (p = 0.84) or new-onset erectile dysfunction (ED) at 12 months (p = 0.08) following surgery. On multivariable regression, prior interventional BPH therapy was associated with increased risk of urinary retention (OR 1.9, 95%, p = 0.015) and new-onset urinary incontinence (OR 2.13, p < 0.001). The estimated 5 years Kaplan–Meier survival analysis showed no statistically significant difference (p = 0.3) in biochemical progression free survival between those who underwent interventional BPH therapy compared with those who did not. Local disease recurrence assessed by post cryoablation positive for-cause prostate biopsy showed no significant difference between the two groups (25.4% vs. 28.7%, p = 0.59).

Conclusions

Prior interventional BPH therapy did not affect the oncologic outcomes nor did it increase the risk of rectourethral fistula or ED in sexually performing patients prior to cryosurgery. Prior interventional BPH therapy was associated with increased risk of urinary retention and incontinence after primary whole-gland prostate cryoablation for prostate cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Data distribution.
Fig. 2

Similar content being viewed by others

References

  1. Chang RT, Kirby R, Challacombe BJ. Is there a link between BPH and prostate cancer? Practitioner. 2012;256:13–2.

    CAS  PubMed  Google Scholar 

  2. Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015;22:1–6.

    PubMed  Google Scholar 

  3. Bashir MN. Epidemiology of prostate cancer. Asian Pac J Cancer Prev. 2015;16:5137–41.

    Article  Google Scholar 

  4. Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, et al. Clinically localized prostate cancer: AUA/ASTRO/SUO Guideline. Part II: recommended approaches and details of specific care options. J Urol. 2018;199:990–7.

    Article  Google Scholar 

  5. Biers S, Sievert KD, Thiruchelvam N. Overactive bladder syndrome and lower urinary tract symptoms after prostate cancer treatment. Curr Opin Urol. 2017;27:307–13.

    Article  Google Scholar 

  6. Ishiyama H, Hirayama T, Jhaveri P, Satoh T, Paulino AC, Xu B, et al. Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review. Am J Clin Oncol. 2014;37:297–304.

    Article  Google Scholar 

  7. Cozzarini C, Rancati T, Palorini F, Avuzzi B, Garibaldi E, Balestrini D, et al. Patient-reported urinary incontinence after radiotherapy for prostate cancer: quantifying the dose-effect. Radiother Oncol. 2017;125:101–6.

    Article  Google Scholar 

  8. Lodeizen O, de Bruin M, Eggener S, Crouzet S, Ghai S, Varkarakis I, et al. Ablation energies for focal treatment of prostate cancer. World J Urol. 2019;37:409–18.

    Article  Google Scholar 

  9. Roberts CB, Jang TL, Shao YH, Kabadi S, Moore DF, Lu-Yao GL. Treatment profile and complications associated with cryotherapy for localized prostate cancer: a population-based study. Prostate Cancer Prostatic Dis. 2011;14:313–9.

    Article  CAS  Google Scholar 

  10. Shinohara K, Connolly JA, Presti JC Jr, Carroll PR. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996;156:115–21.

    Article  CAS  Google Scholar 

  11. Temml C, Haidinger G, Schmidbauer J, Schatzl G, Madersbacher S. Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life. Neurourol Urodyn. 2000;19:259–71.

    Article  CAS  Google Scholar 

  12. Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol. 2009;27:4300–5.

    Article  Google Scholar 

  13. Colombo R, Naspro R, Salonia A, Montorsi F, Raber M, Suardi N, et al. Radical prostatectomy after previous prostate surgery: clinical and functional outcomes. J Urol. 2006;176:2459–63.

    Article  Google Scholar 

  14. Teber D, Cresswell J, Ates M, Erdogru T, Hruza M, Gözen AS, et al. Laparoscopic radical prostatectomy in clinical T1a and T1b prostate cancer: oncologic and functional outcomes-a matched-pair analysis. Urology. 2009;73:577–81.

    Article  Google Scholar 

  15. Devisetty K, Zorn KC, Katz MH, Jani AB, Liauw SL. External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity. Int J Radiat Oncol Biol Phys. 2010;77:1060–5.

    Article  Google Scholar 

  16. Nag S, Beyer D, Friedland J, Grimm P, Nath R. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44:789–99.

    Article  CAS  Google Scholar 

  17. Moran BJ, Stutz MA, Gurel MH. Prostate brachytherapy can be performed in selected patients after transurethral resection of the prostate. Int J Radiat Oncol Biol Phys. 2004;59:392–6.

    Article  Google Scholar 

  18. Stone NN, Ratnow ER, Stock RG. Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation. Tech Urol. 2000;6:123–7.

    CAS  PubMed  Google Scholar 

  19. Brousil P, Hussain M, Lynch M, Laing RW, Langley SE. Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasible. BJU Int. 2015;115:580–6.

    Article  Google Scholar 

  20. Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180:1993–2004.

    Article  Google Scholar 

  21. Ullal AV, Korets R, Katz AE, Wenske S. A report on major complications and biochemical recurrence after primary and salvage cryosurgery for prostate cancer in patients with prior resection for benign prostatic hyperplasia: a single-center experience. Urology. 2013;82:648–52.

    Article  Google Scholar 

  22. Xu N, Chen SH, Xue XY, Wei Y, Zheng Q-S, Li X-D, et al. Older age and larger prostate volume are associated with stress urinary incontinence after plasmakinetic enucleation of the prostate. Biomed Res Int. 2017;2017:6923290.

    PubMed  PubMed Central  Google Scholar 

  23. Grossgold E, Given R, Ruckle H, Jones JS. Does neoadjuvant androgen deprivation therapy before primary whole gland cryoablation of the prostate affect the outcome? Urology. 2014;83:379–83.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urology Department, University Hospital Cleveland Medical Center, Cleveland, OH, USA

    Ahmed ElShafei, Adam Calaway, Austin J. Fernstrum, Adonis Hijaz, Wade Muncey, Anood Alfahmy, Amr Mahran & Kirtishri Mishra

  2. Urology Department, Al Kasr Al Aini Hospital, Cairo, Egypt

    Ahmed ElShafei

  3. Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA

    Molly DeWitt-Foy

  4. INOVA, Falls Church, VA, USA

    J. Stephen Jones

  5. Duke University, Durham, NC, USA

    Thomas J. Polascik

Authors
  1. Ahmed ElShafei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Molly DeWitt-Foy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adam Calaway
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Austin J. Fernstrum
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adonis Hijaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wade Muncey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anood Alfahmy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Amr Mahran
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kirtishri Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. Stephen Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Thomas J. Polascik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas J. Polascik.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ElShafei, A., DeWitt-Foy, M., Calaway, A. et al. Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer?. Prostate Cancer Prostatic Dis 24, 507–513 (2021). https://doi.org/10.1038/s41391-020-00306-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-020-00306-z

Search

Advanced search

Quick links